DE69330842D1 - Verwendung von Monosialogangliosid GMl oder von N-Dichlor-Acetyl-lyso-GMl zur Vorbeugung oder zur Umkehrung der von einer Langzeitbehandlung mit L-DOPA bei der Therapie von Morbus Parkinson induzierten neuronale Degeneration - Google Patents
Verwendung von Monosialogangliosid GMl oder von N-Dichlor-Acetyl-lyso-GMl zur Vorbeugung oder zur Umkehrung der von einer Langzeitbehandlung mit L-DOPA bei der Therapie von Morbus Parkinson induzierten neuronale DegenerationInfo
- Publication number
- DE69330842D1 DE69330842D1 DE69330842T DE69330842T DE69330842D1 DE 69330842 D1 DE69330842 D1 DE 69330842D1 DE 69330842 T DE69330842 T DE 69330842T DE 69330842 T DE69330842 T DE 69330842T DE 69330842 D1 DE69330842 D1 DE 69330842D1
- Authority
- DE
- Germany
- Prior art keywords
- gml
- treatment
- dopa
- parkinson
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI920591A IT1254280B (it) | 1992-03-13 | 1992-03-13 | Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69330842D1 true DE69330842D1 (de) | 2001-10-31 |
DE69330842T2 DE69330842T2 (de) | 2002-04-04 |
Family
ID=11362423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69330842T Expired - Lifetime DE69330842T2 (de) | 1992-03-13 | 1993-03-12 | Verwendung von Monosialogangliosid GMl oder von N-Dichlor-Acetyl-lyso-GMl zur Vorbeugung oder zur Umkehrung der von einer Langzeitbehandlung mit L-DOPA bei der Therapie von Morbus Parkinson induzierten neuronale Degeneration |
Country Status (8)
Country | Link |
---|---|
US (1) | US6620792B1 (de) |
EP (2) | EP0630250A1 (de) |
JP (1) | JP2872809B2 (de) |
AT (1) | ATE206053T1 (de) |
DE (1) | DE69330842T2 (de) |
ES (1) | ES2161953T3 (de) |
IT (1) | IT1254280B (de) |
WO (1) | WO1993017691A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1259176B (it) * | 1992-10-23 | 1996-03-11 | Fidia Spa | Composizioni farmaceutiche comprendenti monosialoganglioside gm1 (o suo derivato) e fattore neuronotrofico ciliare (cntf) atte al trattamento di patologie del sistema nervoso |
MXPA04001831A (es) * | 2001-08-29 | 2004-07-08 | Neose Technologies Inc | Nuevos derivados sinteticos de gangliosidos y composiciones de los mismos. |
EP1367395A1 (de) | 2002-05-02 | 2003-12-03 | B.R.A.H.M.S Aktiengesellschaft | Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern |
EP1358910A1 (de) * | 2002-05-02 | 2003-11-05 | B.R.A.H.M.S Aktiengesellschaft | Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen |
US7943750B2 (en) | 2007-06-18 | 2011-05-17 | Laboratoire Medidom S.A. | Process for obtaining pure monosialoganglioside GM1 for medical use |
CN101732331B (zh) * | 2008-11-20 | 2012-05-23 | 北京四环制药有限公司 | 一种单唾液酸四己糖神经节苷脂钠与谷氨酸的组合物 |
US9463186B2 (en) | 2013-04-15 | 2016-10-11 | Northwestern University | Treatment for dopaminergic disorders |
CN104490837A (zh) * | 2014-12-30 | 2015-04-08 | 哈尔滨医科大学科技开发总公司 | 单唾液酸四己糖神经节苷脂钠的口服制剂 |
RU2632710C2 (ru) * | 2016-03-31 | 2017-10-09 | Лонг Шенг Фарма Лимитед | Способ получения натрий моносиалового ганглиозида и нейропротекторное средство на его основе |
CN108815131B (zh) * | 2018-09-11 | 2021-01-01 | 四川奇格曼药业有限公司 | 一种神经节苷脂缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1199116B (it) | 1984-07-03 | 1988-12-30 | Fidia Farmaceutici | Derivati di gangliosidi |
IT1208751B (it) * | 1986-06-30 | 1989-07-10 | Fidia Farmaceutici | Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali |
IT1235161B (it) * | 1988-12-02 | 1992-06-22 | Fidia Farmaceutici | Derivati di lisogangliosidi |
IT1249034B (it) * | 1990-06-29 | 1995-02-11 | Fidia Spa | Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi |
IT1253832B (it) * | 1991-08-01 | 1995-08-29 | Fidia Spa | Derivati di gangliosidi |
-
1992
- 1992-03-13 IT ITMI920591A patent/IT1254280B/it active
-
1993
- 1993-03-12 JP JP5515350A patent/JP2872809B2/ja not_active Expired - Fee Related
- 1993-03-12 DE DE69330842T patent/DE69330842T2/de not_active Expired - Lifetime
- 1993-03-12 EP EP93906509A patent/EP0630250A1/de not_active Withdrawn
- 1993-03-12 WO PCT/EP1993/000571 patent/WO1993017691A2/en not_active Application Discontinuation
- 1993-03-12 AT AT96116051T patent/ATE206053T1/de not_active IP Right Cessation
- 1993-03-12 ES ES96116051T patent/ES2161953T3/es not_active Expired - Lifetime
- 1993-03-12 EP EP96116051A patent/EP0770389B1/de not_active Expired - Lifetime
-
1994
- 1994-09-12 US US08/304,391 patent/US6620792B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69330842T2 (de) | 2002-04-04 |
EP0770389B1 (de) | 2001-09-26 |
US6620792B1 (en) | 2003-09-16 |
JPH07508258A (ja) | 1995-09-14 |
IT1254280B (it) | 1995-09-14 |
ITMI920591A1 (it) | 1993-09-13 |
ES2161953T3 (es) | 2001-12-16 |
WO1993017691A2 (en) | 1993-09-16 |
ATE206053T1 (de) | 2001-10-15 |
ITMI920591A0 (it) | 1992-03-13 |
EP0630250A1 (de) | 1994-12-28 |
JP2872809B2 (ja) | 1999-03-24 |
WO1993017691A3 (en) | 1993-11-11 |
EP0770389A1 (de) | 1997-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59107331D1 (de) | Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen | |
DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
DK0768312T3 (da) | Anvendelse af K-252a-derivater til at forbedre funktionen af en striatal neuron | |
OA08581A (en) | Treatment of diseases caused by retroviruses. | |
BR8804188A (pt) | Processo para controlar a aspereza da superficie de um filme | |
DK164688A (da) | Huderstatning | |
DE3582894D1 (de) | Hautbehandlungsmittel. | |
DK90089A (da) | Hudbehandlingspraeparat | |
DE69330842D1 (de) | Verwendung von Monosialogangliosid GMl oder von N-Dichlor-Acetyl-lyso-GMl zur Vorbeugung oder zur Umkehrung der von einer Langzeitbehandlung mit L-DOPA bei der Therapie von Morbus Parkinson induzierten neuronale Degeneration | |
IT1221826B (it) | Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi | |
ATE109350T1 (de) | Verwendung von ofloxacin oder dessen salzen zur herstellung eines lokalpräparats für die behandlung von otopathie. | |
BR8501792A (pt) | Autoclave para o tratamento de licor de cacau | |
IT1212143B (it) | Composizione ad attivita'tricogena. | |
IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
LV10574A (lv) | Trinitrobenzolu vai karminskabes pielietosana veza vai virali slimibu arstesana | |
DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
ATE162717T1 (de) | Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten | |
DK671187D0 (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdomme | |
MX164619B (es) | Composicion para el tratamiento de lesiones cutaneas | |
NO960545D0 (no) | Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin | |
DK526985A (da) | Polycykliske biocide forbindelser, deres fremstilling og mellemprodukter herved samt deres anvendelse i medicinske praeparationer | |
IT8519042A0 (it) | Impiego di chinoloni nel trattamento di malattie cardiache.! | |
LV10391A (lv) | Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai | |
ES2129401T3 (es) | Uso de un compuesto terapeutico para el tratamiento de bronquitis. | |
ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LABORATOIRE MEDIDOM S.A., GENF/GENEVE, CH |